Bercovici J P, Tater D, Khoury S, Charles J F, Floch J, Leroy J P
J Clin Endocrinol Metab. 1981 Dec;53(6):1291-6. doi: 10.1210/jcem-53-6-1291.
A patient with a testicular interstitial cell tumor and gynecomastia is reported. The testicular tumor was capable of aromatizing 8.3% testosterone. Spermatic venous samples taken from the tumor-bearing side had marked elevations of 17 beta-estradiol (E2), progesterone, and 17-hydroxyprogesterone (170 HP). The progesterone to 17OHP and 17OHP to androstene-dione ratios suggested an enzymatic block of 17 alpha-hydroxylase and 17-20 lyase possibly secondary to locally produced E2. The E2 produced by the tumor appeared to suppress gonadotropin secretion. The plasma testosterone and gonadotropin levels rose within 7 days after the removal of tumor, and the gynecomastia began to decrease.
报告了一例患有睾丸间质细胞瘤和男性乳腺增生症的患者。该睾丸肿瘤能够将8.3%的睾酮芳香化。取自患侧的精索静脉样本中,17β-雌二醇(E2)、孕酮和17-羟孕酮(170 HP)显著升高。孕酮与17OHP以及17OHP与雄烯二酮的比值表明可能存在17α-羟化酶和17-20裂解酶的酶促阻滞,这可能继发于局部产生的E2。肿瘤产生的E2似乎抑制了促性腺激素的分泌。切除肿瘤后7天内,血浆睾酮和促性腺激素水平升高,男性乳腺增生开始减轻。